Mostrando 10 resultados de: 10
Filtros aplicados
Publisher
Vessel Plus(3)
Revista Latinoamericana de Hipertension(2)
Current Pharmaceutical Design(1)
F1000Research(1)
International Journal of Molecular Sciences(1)
Clinical-epidemiological analysis of hdl2 and hdl3 subfractions in adults from maracaibo city, venezuela
ArticleAbstract: Objective: To carry out a clinical-epidemiological analysis of high-density lipoprotein cholesterolPalabras claves:Cholesterol, HDL, Epidemiology (source: MeSH NLM), Lipoproteins, HDL2, Lipoproteins, HDL3, RISK FACTORSAutores:Alex Patricio Morales-Carrasco, Calvo M.J., González M.C., Linares S., Martínez M.S., Nava M., Olivar L.C., Ortega A., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusAutomatic segmentation of the left atrium in cardiac computed tomography
ArticleAbstract: The present work proposes a technique for the automatic segmentation of the left atrium (LA) in 10 tPalabras claves:Computerized tomography, Global Similarity Enhancement, Left atrium, segmentationAutores:Chacón J.G., Contreras J., Graterol M., Huerfano Y., Joselyn Zula, Rianõ-Wilches D., Rojas-Quintero J., Salazar-Vílchez J., Valbuena O., Valmore Bermúdez, Vera M., Wilches-Duran S.Fuentes:googlescopusEnergetic metabolism in cardiomyocytes: molecular basis of heart ischemia and arrhythmogenesis
ReviewAbstract: Cardiac muscle contraction is a strictly regulated process which conjugates a series of electrophysiPalabras claves:Arrhythmias, cardiomyocyte, ischemia, myocardial infarction, Myocardial metabolismAutores:Chávez-Castillo M., García A., Luzardo E., Martínez M.S., Olivar L.C., Quintero J.J.R., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusErratum: Energetic metabolism in Cardiomyocytes: Molecular basis of heart ischemia and arrhythmogenesis (Vessel Plus (2017) 1 (230-241) DOI: 10.20517/2574-1209.2017.34)
OtherAbstract: The original article was published on 28 Dec 2017. After the publication of the article named “EnergPalabras claves:Autores:Chávez-Castillo M., García A., Luzardo E., Martínez M.S., Olivar L.C., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusNon-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusOmega-3 polyunsaturated fatty acids and cardiovascular health: a molecular view into structure and function
ReviewAbstract: Given the notorious impact of cardiovascular disease (CVD) as the current leading cause of mortalityPalabras claves:Cardiovascular disease, Docosahexaeonic acid, Eicosapentaenoic acid, Omega-3 polyunsaturated fatty acidsAutores:Calvo M.J., Chávez-Castillo M., Luzardo E., Martínez M.S., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Velasco M., Villasmil N.Fuentes:scopusImportance of high triglycerides levels between novel coronary risk factors
ArticleAbstract: Introduction The analysis of new cardiovascular risk factors is under an extensive debate in the carPalabras claves:Insulin, lipids, prevention, RISK FACTORSAutores:Añez-Ramos R., Calvo M.J., González M.C., Graterol M., Hernández J.D., Martínez M.S., Rivas-Ríos J.R., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusPhytotherapy for cardiovascular disease: A bench-to-bedside approach
ReviewAbstract: At present, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality world-Palabras claves:atherosclerosis, Cardiovascular disease, dyslipidemia, Hypertension, Medicinal herbs, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Ortega A., Pírela D., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopusSpecialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
ReviewAbstract: Cardiovascular disease (CVD) is a global public health issue due to its high morbidity, mortality, aPalabras claves:atherosclerosis, inflammation, Intimal hyperplasia, Reperfusion injury, resolution, Specialized proresolving mediatorsAutores:Añez-Ramos R., Castro A., Dávila L.C.A., de Sanctis J.B., Diaz A., Durán-Agüero S., Galbán N., González M.C., Nava M., Parra H., Pírela D., Rojas-Gómez D.M., Salazar-Vílchez J., Valmore Bermúdez, Villasmil N.Fuentes:scopus